Biomedical Innovation: A Risky Business at Risk | Science Translational Medicine

Skip to main content

ScienceMag.org

Read our COVID-19 research and news.

Article Information

vol. 3 no. 96 96cm23

DOI:

https://doi.org/10.1126/scitranslmed.3002459

PubMed:

Published By:

American Association for the Advancement of Science

Print ISSN:

Online ISSN:

History:

.

Copyright & Usage:

Copyright © 2011, American Association for the Advancement of Science

Author Information

Richard S. Stack¹,²,^* and
Robert A. Harrington³

¹SyneCor, Chapel Hill, NC 27517, USA.
²Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
³Department of Medicine, Duke University Medical Center, and Duke Clinical Research Institute, Durham, NC 27710, USA.

↵*Corresponding author. E-mail: rstack{at}synecor.com

Altmetric

Article usage

Article usage: August 2011 to January 2021

	Abstract	Full	Pdf
Aug 2011	4462	218	188
Sep 2011	834	10	65
Oct 2011	261	8	34
Nov 2011	157	2	10
Dec 2011	147	2	12
Jan 2012	142	7	15
Feb 2012	115	5	12
Mar 2012	110	5	16
Apr 2012	101	1	8
May 2012	100	4	8
Jun 2012	80	3	9
Jul 2012	89	1	3
Aug 2012	83	4	2
Sep 2012	65	7	10
Oct 2012	91	2	7
Nov 2012	67	3	6
Dec 2012	84	1	2
Jan 2013	78	4	6
Feb 2013	53	2	3
Mar 2013	55	0	1
Apr 2013	70	4	4
May 2013	82	0	3
Jun 2013	66	1	4
Jul 2013	55	1	2
Aug 2013	36	4	3
Sep 2013	35	7	6
Oct 2013	61	34	16
Nov 2013	33	9	5
Dec 2013	29	11	11
Jan 2014	38	29	11
Feb 2014	46	14	6
Mar 2014	40	3	6
Apr 2014	48	12	11
May 2014	69	6	6
Jun 2014	51	5	3
Jul 2014	72	3	10
Aug 2014	50	2	8
Sep 2014	23	3	5
Oct 2014	28	9	11
Nov 2014	61	5	6
Dec 2014	37	4	14
Jan 2015	40	4	15
Feb 2015	14	8	6
Mar 2015	29	1	4
Apr 2015	19	11	7
May 2015	8	11	6
Jun 2015	13	8	5
Jul 2015	15	11	2
Aug 2015	23	7	5
Sep 2015	10	7	8
Oct 2015	3	0	5
Nov 2015	9	0	6
Dec 2015	13	3	4
Jan 2016	10	2	8
Feb 2016	12	5	16
Mar 2016	18	4	16
Apr 2016	13	2	14
May 2016	18	4	8
Jun 2016	15	11	16
Jul 2016	17	7	12
Aug 2016	17	13	17
Sep 2016	22	12	8
Oct 2016	34	9	18
Nov 2016	17	4	4
Dec 2016	21	12	2
Jan 2017	12	10	10
Feb 2017	29	11	8
Mar 2017	17	11	6
Apr 2017	17	16	22
May 2017	19	15	6
Jun 2017	16	13	7
Jul 2017	21	18	5
Aug 2017	36	18	11
Sep 2017	27	18	11
Oct 2017	30	21	2
Nov 2017	32	29	6
Dec 2017	25	22	9
Jan 2018	22	12	4
Feb 2018	20	9	6
Mar 2018	23	19	11
Apr 2018	29	23	11
May 2018	40	31	19
Jun 2018	47	39	21
Jul 2018	12	19	10
Aug 2018	2	51	5
Sep 2018	1	119	18
Oct 2018	2	126	14
Nov 2018	0	155	8
Dec 2018	2	114	10
Jan 2019	1	102	6
Feb 2019	9	91	9
Mar 2019	4	31	6
Apr 2019	7	23	4
May 2019	11	36	69
Jun 2019	4	21	4
Jul 2019	3	10	11
Aug 2019	4	13	22
Sep 2019	1	10	9
Oct 2019	7	17	11
Nov 2019	4	10	3
Dec 2019	2	10	8
Jan 2020	4	12	11
Feb 2020	5	17	10
Mar 2020	9	12	11
Apr 2020	4	14	4
May 2020	3	19	3
Jun 2020	1	8	4
Jul 2020	2	8	4
Aug 2020	3	8	10
Sep 2020	2	12	5
Oct 2020	2	31	6
Nov 2020	3	20	19
Dec 2020	2	19	24
Jan 2021	2	6	3

Science Translational Medicine: 3 (96)

Science Translational Medicine

Vol 3, Issue 96
17 August 2011

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Translational Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Biomedical Innovation: A Risky Business at Risk

Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

Your Personal Message

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Powerpoint
Print
Alerts

Please log in to add an alert for this article.

Log In with your AAAS ID

Sign In to Email Alerts with your Email Address
Email
Citation tools
Biomedical Innovation: A Risky Business at Risk

By Richard S. Stack, Robert A. Harrington

Science Translational Medicine17 Aug 2011 : 96cm23

Biomedical innovation needs a new regulatory framework that better balances the benefits and risks to the public of pioneering products.

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share

Biomedical Innovation: A Risky Business at Risk

By Richard S. Stack, Robert A. Harrington

Science Translational Medicine17 Aug 2011 : 96cm23

Biomedical innovation needs a new regulatory framework that better balances the benefits and risks to the public of pioneering products.

Share This Article:

My saved folders

Save to my folders

Log In with your AAAS ID

Stay Connected to Science Translational Medicine

Citing Articles in: